Related Experiment Video
Updated: Aug 7, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD
1Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, UK. t.h.j.goodship@ncl.ac.uk
Atypical hemolytic uremic syndrome is linked to C-terminal Factor H mutations. New research reveals N-terminal Factor H mutations also cause membranoproliferative glomerulonephritis type II, clarifying disease mechanisms.
Area of Science:
- Complement system biology
- Nephrology
- Genetic disorders
Background:
- Factor H mutations are linked to kidney diseases like atypical hemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis type II (MPGN II).
- Typically, C-terminal Factor H mutations are associated with aHUS, while homozygous Factor H deficiency often presents as MPGN II.
Discussion:
- Licht et al. identified a novel mutation in the N-terminal region of Factor H associated with MPGN II.
- This finding expands the understanding of Factor H's role in complement regulation and kidney disease pathogenesis.
- The study highlights the diverse clinical manifestations resulting from Factor H dysfunction.
Key Insights:
- Factor H mutations in different regions (N-terminal vs. C-terminal) can lead to distinct kidney diseases.
- N-terminal Factor H mutations are implicated in the development of MPGN II.
- Understanding these genotype-phenotype correlations is crucial for diagnosing and managing complement-mediated kidney diseases.
Outlook:
- Further research into Factor H mutations may reveal new therapeutic targets for MPGN II and related disorders.
- Investigating the precise mechanisms by which N-terminal Factor H mutations disrupt complement regulation is warranted.
- This study underscores the importance of comprehensive genetic analysis in patients with unexplained glomerulonephritis.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Genetic Lingo
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...